The four most common mutations are large, intronic, hexanucleotide repeat (G4C2) expansions in chromosome 9 open reading frame 72 (C9orf72) (DeJesus-Hernandez et al., 2011; Renton et al., 2011), and dominant mutations in superoxide dismutase 1 (SOD1) (Rosen et al., 1993), transactive-region DNA binding protein (TARDBP encoding TDP-43) (Sreedharan et al., 2008), and fused in sarcoma (FUS, a.k.a. translocated in liposarcoma, TLS) (Kwiatkowski et al., 2009; Vance et al., 2009). This evidence concerns the gene TARDBP and Tumor Lysis Syndrome.